Management of Low Free T4/T3 with Normal TSH

Medication‑Induced Thyroid Hormone Abnormalities

Certain drugs (e.g., amiodarone, high‑dose glucocorticoids, dopamine) can lower free T4 and free T3 while leaving TSH normal or low‑normal, reflecting drug‑mediated suppression of thyroid hormone synthesis and secretion【1】.
Dopamine and high‑dose glucocorticoids specifically suppress TSH release and reduce peripheral thyroid hormone levels, producing the same laboratory pattern【1】.
After treatment for hyperthyroidism, delayed recovery of pituitary TSH secretion may transiently generate low free T4/T3 with normal TSH【1】.
The convalescent phase of destructive thyroiditis can also present with low free T4/T3 and a non‑elevated TSH【1】.

Before starting levothyroxine, clinicians must exclude adrenal insufficiency; initiating thyroid hormone without adequate glucocorticoid coverage can trigger life‑threatening adrenal crisis【2】.
If adrenal insufficiency is confirmed or strongly suspected, hydrocortisone should be started at least one week prior to levothyroxine therapy【2】.
Free T4 (not TSH) should be used for dose titration, with monitoring every 6–8 weeks to achieve target levels in the upper half of the reference range【2】.

NTIS does not require thyroid‑specific therapy; the primary approach is aggressive treatment of the underlying systemic illness【3】.
Routine administration of levothyroxine in NTIS has shown no measurable clinical benefit, and therefore is not recommended【3】.
Limited data suggest possible benefit of triiodothyronine (T3) in highly selected cases, but the evidence is insufficient to support routine use【3】.
Thyroid function tests (TSH and free T4) should be repeated 3–6 months after recovery from the acute illness to confirm normalization of the hypothalamic‑pituitary‑thyroid axis【3】.